Inventor · disambiguated record
Steven Rust
Also filed as: RUST STEVEN · RUST STEVEN R
10 granted patents·7 pending applications·71 citations·filing 1999–2025
88Inventor score
Top patents by PatentIndex Score
17 records- 0190US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0289US10844114B2Anti-Pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Nov 24, 2020·3 cites·21 claims
- 0389US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0487US10370436B2Anti-pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Aug 6, 2019·5 cites·5 claims
- 0583US9403901B2Anti-pseudomonas Psl binding molecules and uses thereofDIGIANDOMENICO ANTONIO·Filed 2012·Granted Aug 2, 2016·9 cites·14 claims
- 0682US9884902B2CTLA-4 variantsMEDIMMUNE LLC·Filed 2013·Granted Feb 6, 2018·9 cites·15 claims
- 0781US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0877US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0972US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1069US2021130442A1Anti-pseudomonas psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1166US2022195037A1Compositions and methods for inhibiting cancer stem cellsMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 1260US6054148AMethod and compositions for ensiling silageUNIV MICHIGAN STATE·Filed 1999·Granted Apr 25, 2000·30 cites·13 claims
- 1356US11192948B2Compositions and methods for inhibiting cancer stem cellsMEDIMMUNE LTD·Filed 2016·Granted Dec 7, 2021·0 cites·13 claims
- 1448US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 1545US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 1644US2018208639A1CTLA-4 VariantsMEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 1736US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →